Therapeutic strategies to target connective tissue growth factor in fibrotic lung diseases

被引:14
|
作者
Isshiki, Takuma [1 ,2 ,3 ]
Naiel, Safaa [1 ,2 ]
Vierhout, Megan [1 ,2 ]
Otsubo, Kohei [1 ,4 ]
Ali, Pareesa [1 ,2 ]
Tsubouchi, Kazuya [1 ,4 ]
Yazdanshenas, Parichehr [1 ,2 ]
Kumaran, Vaishnavi [1 ,2 ]
Dvorkin-Gheva, Anna [2 ]
Kolb, Martin R. J. [1 ]
Ask, Kjetil [1 ,2 ,5 ,6 ]
机构
[1] McMaster Univ, Firestone Inst Resp Hlth, Dept Med, 5o Charlton Ave East, Hamilton, ON L8N 4A6, Canada
[2] McMaster Univ, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, 1280 Main St West, Hamilton, ON L8S 48L, Canada
[3] Toho Univ, Dept Resp Med, Sch Med, 6-11-1 Omori Nisi,Ota ku, Tokyo 1438541, Japan
[4] Kyushu Univ, Res Inst Dis Chest, Grad Sch Med Sci, 3-1-1 Maidashi,Higashi Ku, Fukuoka 8128582, Japan
[5] McMaster Univ, Dept Med, Luke Wing,Rm L314-5,50 Charlton Ave East, Hamilton, ON L8N 4A6, Canada
[6] Firestone Inst Resp Hlth, Res Inst St Joes Hamilton, Luke Wing,Rm L314-5,50 Charlton Ave East, Hamilton, ON L8N 4A6, Canada
关键词
CTGF; Interstitial pneumonia; IPF; Pulmonary fibrosis; Therapeutics; IDIOPATHIC PULMONARY-FIBROSIS; ALVEOLAR EPITHELIAL-CELLS; C-TERMINAL DOMAIN; CCN2; EXPRESSION; GENE-PRODUCT; FACTOR CTGF; I COLLAGEN; STEM-CELLS; TGF-BETA; FIBROBLASTS;
D O I
10.1016/j.pharmthera.2023.108578
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The treatment of interstitial lung diseases, including idiopathic pulmonary fibrosis (IPF), remains challenging as current available antifibrotic agents are not effective in halting disease progression. Connective tissue growth factor (CTGF), also known as cellular communication factor 2 (CCN2), is a member of the CCN family of proteins that regulates cell signaling through cell surface receptors such as integrins, the activity of cytokines/growth factors, and the turnover of extracellular matrix (ECM) proteins. Accumulating evidence indicates that CTGF plays a crucial role in promoting lung fibrosis through multiple processes, including inducing transdifferentiation of fibroblasts to myofibroblasts, epithelial-mesenchymal transition (EMT), and cooperating with other fibrotic mediators such as TGF-beta. Increased expression of CTGF has been observed in fibrotic lungs and inhibiting CTGF signaling has been shown to suppress lung fibrosis in several animal models. Thus, the CTGF signaling pathway is emerging as a potential therapeutic target in IPF and other pulmonary fibrotic conditions. This review provides a comprehensive overview of the current evidence on the pathogenic role of CTGF in pulmonary fibrosis and discusses the current therapeutic agents targeting CTGF using a systematic review approach. (c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases
    Fu, Minyang
    Peng, Dandan
    Lan, Tianxia
    Wei, Yuquan
    Wei, Xiawei
    ACTA PHARMACEUTICA SINICA B, 2022, 12 (04) : 1740 - 1760
  • [2] Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases
    Gressner, Olav A.
    Gressner, Axel M.
    LIVER INTERNATIONAL, 2008, 28 (08) : 1065 - 1079
  • [3] The Axis of Thrombospondin-1, Transforming Growth Factor Beta and Connective Tissue Growth Factor: An Emerging Therapeutic Target in Rheumatoid Arthritis
    Rico, Mario C.
    Rough, James J.
    Del Carpio-Cano, Fabiola E.
    Kunapuli, Satya P.
    DeLa Cadena, Raul A.
    CURRENT VASCULAR PHARMACOLOGY, 2010, 8 (03) : 338 - 343
  • [4] Connective-Tissue Growth Factor Contributes to TGF-β1-induced Lung Fibrosis
    Yanagihara, Toyoshi
    Tsubouchi, Kazuya
    Gholiof, Mahsa
    Chong, Sy Giin
    Lipson, Kenneth E.
    Zhou, Quan
    Scallan, Ciaran
    Upagupta, Chandak
    Tikkanen, Jussi
    Keshavjee, Shaf
    Ask, Kjetil
    Kolb, Martin R. J.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2022, 66 (03) : 260 - 270
  • [5] Nerve Growth Factor: A Potential Therapeutic Target for Lung Diseases
    Liu, Piaoyang
    Li, Shun
    Tang, Liling
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (17)
  • [6] Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer
    Moran-Jones, Kim
    Gloss, Brian S.
    Murali, Rajmohan
    Chang, David K.
    Colvin, Emily K.
    Jones, Marc D.
    Yuen, Samuel
    Howell, Viive M.
    Brown, Laura M.
    Wong, Carol W.
    Spong, Suzanne M.
    Scarlett, Christopher J.
    Hacker, Neville F.
    Ghosh, Sue
    Mok, Samuel C.
    Birrer, Michael J.
    Samimi, Goli
    ONCOTARGET, 2015, 6 (42) : 44551 - 44562
  • [7] Connective Tissue Growth Factor: Regulation, Diseases, and Drug Discovery
    Ren, Meishen
    Yao, Shanshan
    Chen, Tienan
    Luo, Hang
    Tao, Xiaohui
    Jiang, Hewen
    Yang, Xin
    Zhang, Huarui
    Yu, Sifan
    Wang, Yin
    Lu, Aiping
    Zhang, Ge
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
  • [8] Therapeutic strategies targeting pro-fibrotic macrophages in interstitial lung disease
    Isshiki, Takuma
    Vierhout, Megan
    Naiel, Safaa
    Ali, Pareesa
    Yazdanshenas, Parichehr
    Kumaran, Vaishnavi
    Yang, Zi
    Dvorkin-Gheva, Anna
    Rullo, Anthony F.
    Kolb, Martin R. J.
    Ask, Kjetil
    BIOCHEMICAL PHARMACOLOGY, 2023, 211
  • [9] Therapeutic Approach to Adult Fibrotic Lung Diseases
    Adegunsoye, Ayodeji
    Strek, Mary E.
    CHEST, 2016, 150 (06) : 1371 - 1386
  • [10] Inhibition of each module of connective tissue growth factor as a potential therapeutic target for rheumatoid arthritis
    Miyashita, Tomoko
    Morimoto, Shinji
    Fujishiro, Maki
    Hayakawa, Kunihiro
    Suzuki, Satoshi
    Ikeda, Keigo
    Miyazawa, Keiji
    Morioka, Megumi
    Takamori, Kenji
    Ogawa, Hideoki
    Sekigawa, Iwao
    Takasaki, Yoshinari
    AUTOIMMUNITY, 2016, 49 (02) : 109 - 114